Specifically, we confirmed that TC2N acts as a candidate oncogene in lung cancer by promoting cell proliferation and resisting apoptosis through the inhibition of the p53 signaling pathway, while facilitating metastasis via the activation of the NF-κB signaling pathway. Here, TC2N is linked to lung carcinoma.